CINCINNATI, May 24, 2012 - Omnicare, Inc. (NYSE:OCR), today announced the appointment of Sam R. Leno to its Board of Directors and he will also become a member of the Audit Committee.
Mr. Leno has more than 40 years of business experience with multinational companies, the vast majority within the healthcare sector. He recently retired as Executive Vice President and Chief Operations Officer at Boston Scientific, where he was responsible for the finance, information systems, operations, business development, strategy and restructuring functions. Mr. Leno previously served as Boston Scientific's Executive Vice President, Finance and Information Systems and Chief Financial Officer. Prior to joining Boston Scientific, he served as Executive Vice President, Corporate Finance and Operations and Chief Financial Officer at Zimmer Holdings, Inc. Mr. Leno has also held Chief Financial Officer positions at Arrow Electronics, Inc., Corporate Express, Inc., and Coram Healthcare. Earlier in his career, he held a variety of senior financial positions at Baxter International, Inc. and American Hospital Supply Corporation. Mr. Leno served as a Lieutenant in the United States Navy and is a Vietnam veteran. He currently serves on the Board of Directors and is Chairman of the Audit Committee of Lantheus MI Holdings, Inc. He is also a member of the Advisory Board of the Harvard Business School Healthcare Initiative. Mr. Leno holds a B.S. Degree in Accounting and an MBA.
"We are pleased to welcome Sam to Omnicare's Board of Directors," said James D. Shelton, Omnicare's Chairman of the Board. "Sam is a highly accomplished executive who brings to the board a broad range of expertise and extensive healthcare experience. We believe Omnicare's shareholders will benefit from his finance and operational experience."
About Omnicare
Omnicare, Inc., a Fortune 400 company based in Cincinnati, Ohio, provides comprehensive pharmaceutical services to patients and providers across North America. As the market-leader in professional pharmacy, related consulting and data management services for skilled nursing, assisted living and other chronic care institutions, Omnicare leverages its unparalleled clinical insight into the geriatric market along with some of the industry's most innovative technological capabilities to the benefit of its long-term care customers. Omnicare also provides key commercialization services for the bio-pharmaceutical industry and end-of-life disease management through its Specialty Care Group. For more information, visit www.omnicare.com (http://www.omnicare.com/).
Forward-looking Statements
In addition to historical information, this report contains certain statements that constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, all statements regarding the intent, belief or current expectations regarding the matters discussed or incorporated by reference in this document (including statements as to "beliefs," "expectations," "anticipations," "intentions" or similar words) and all statements which are not statements of historical fact. Such forward-looking statements, together with other statements that are not historical, are based on management's current expectations and involve known and unknown risks, uncertainties, contingencies and other factors that could cause results, performance or achievements to differ materially from those stated. The most significant of these risks and uncertainties are described in the Company's Form 10-K, Form 10-Q and Form 8-K reports filed with the Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize or should underlying assumptions prove incorrect, the Company's actual results, performance or achievements could differ materially from those expressed in, or implied by, such forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. Except as otherwise required by law, the Company does not undertake any obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
# # #
Contact:
Media:
Tim Canning
(859) 392-7444
tim.canning@omnicare.com (mailto:tim.canning@omnicare.com)
Investors:
Patrick C. Lee
(859) 392-3444
patrick.lee@omnicare.com (mailto:patrick.lee@omnicare.com)
The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.
Source: Omnicare via Thomson Reuters ONE
